SE8901031D0 - NOVEL POLYPEPTIDESHAVING GROWTH FACTOR ACTVIVTY AND ND NUCLEIC ACID SEQUENCES ENCODING THE POLYPEPTIDES - Google Patents
NOVEL POLYPEPTIDESHAVING GROWTH FACTOR ACTVIVTY AND ND NUCLEIC ACID SEQUENCES ENCODING THE POLYPEPTIDESInfo
- Publication number
- SE8901031D0 SE8901031D0 SE8901031A SE8901031A SE8901031D0 SE 8901031 D0 SE8901031 D0 SE 8901031D0 SE 8901031 A SE8901031 A SE 8901031A SE 8901031 A SE8901031 A SE 8901031A SE 8901031 D0 SE8901031 D0 SE 8901031D0
- Authority
- SE
- Sweden
- Prior art keywords
- polypeptides
- growth factor
- polypeptideshaving
- actvivty
- novel
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000003102 growth factor Substances 0.000 title abstract 3
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 102000001301 EGF receptor Human genes 0.000 abstract 3
- 108060006698 EGF receptor Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 150000001945 cysteines Chemical class 0.000 abstract 1
- 239000003226 mitogen Substances 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
Abstract
Polypeptides capable of binding to an epidermal growth factor receptor are provided, as well as precursors thereof, where the polypeptides find analogy with polypeptides coded for by pox viruses. The compounds have a framework structure, particularly involving six cysteines which provide loops analogous to those found in naturally occurring growth factors which bind to an epidermal growth factor receptor. The compounds find use as mitogens, additives in nutrient media, in assays for EGF receptors, and as competitors for other growth factors. The components also find use in wound healing. <IMAGE>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17265388A | 1988-03-24 | 1988-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8901031D0 true SE8901031D0 (en) | 1989-03-22 |
SE8901031L SE8901031L (en) | 1989-09-25 |
Family
ID=22628611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8901031A SE8901031L (en) | 1988-03-24 | 1989-03-22 | NEW POLYPEPTIDES WITH ADDITION FACTOR ACTIVITY AND NUCLEIC ACID SEQUENCES CODING POLYPEPTIDES |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPH0279981A (en) |
KR (1) | KR890014743A (en) |
AU (2) | AU3169589A (en) |
BE (1) | BE1004202A5 (en) |
CH (1) | CH681081A5 (en) |
DE (1) | DE3910084A1 (en) |
DK (1) | DK146789A (en) |
ES (1) | ES2013408A6 (en) |
FI (1) | FI891308A (en) |
FR (1) | FR2632321A1 (en) |
GB (1) | GB2219799B (en) |
GR (1) | GR1000876B (en) |
HU (1) | HUT50501A (en) |
IE (1) | IE890950L (en) |
IL (1) | IL89673A0 (en) |
IT (1) | IT1234961B (en) |
LU (1) | LU87489A1 (en) |
NL (1) | NL8900724A (en) |
NO (1) | NO891273D0 (en) |
NZ (1) | NZ228427A (en) |
PT (1) | PT90118B (en) |
SE (1) | SE8901031L (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0293785A3 (en) * | 1987-05-29 | 1990-05-02 | Oncogen Limited Partnership | Cloning and expression of simian transforming growth factor-ss1 |
CA2037440A1 (en) * | 1990-03-02 | 1991-09-03 | Gregory D. Plowman | Her3: a novel egf receptor homolog |
EP0739984A1 (en) * | 1995-04-26 | 1996-10-30 | San Tumorforschungs-Gmbh | Bivalent polypeptides containing at least two domains |
US6852506B1 (en) | 1996-04-10 | 2005-02-08 | Human Genome Sciences, Inc. | Extracellular/epidermal growth factor-like protein |
JP2000508531A (en) * | 1996-04-10 | 2000-07-11 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Extracellular / epidermal growth factor-like protein |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0108132A1 (en) * | 1982-05-06 | 1984-05-16 | Applied Molecular Genetics Inc. | The manufacture and expression of genes for urogastrone and polypeptide analogs thereof |
JPS6028994A (en) * | 1983-07-08 | 1985-02-14 | Wakunaga Seiyaku Kk | (21-leucine) human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and their preparation |
WO1985002198A1 (en) * | 1983-11-01 | 1985-05-23 | Amgen | Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides |
JP2554459B2 (en) * | 1984-07-02 | 1996-11-13 | アース製薬 株式会社 | β-urogastron gene, corresponding plasmid recombinant and corresponding transformant |
AU600433B2 (en) * | 1984-10-30 | 1990-08-16 | Oncogen | Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides |
GB8507666D0 (en) * | 1985-03-25 | 1985-05-01 | Wellcome Found | Epidermal growth factor production |
US4743679A (en) * | 1986-02-24 | 1988-05-10 | Creative Biomolecules, Inc. | Process for producing human epidermal growth factor and analogs thereof |
GB2210618B (en) * | 1987-10-08 | 1991-10-16 | British Bio Technology | Synthetic egf gene |
ES2081801T3 (en) * | 1987-10-30 | 1996-03-16 | Bristol Myers Squibb Co | EXPRESSION PLASMIDS. |
JP2970811B2 (en) * | 1987-10-30 | 1999-11-02 | オンコゲン ア リミテッド パートナーシップ | Expression systems for preparing polypeptides in prokaryotic cells |
-
1989
- 1989-03-20 IL IL89673A patent/IL89673A0/en unknown
- 1989-03-20 FI FI891308A patent/FI891308A/en not_active IP Right Cessation
- 1989-03-21 NZ NZ228427A patent/NZ228427A/en unknown
- 1989-03-22 NO NO891273A patent/NO891273D0/en unknown
- 1989-03-22 SE SE8901031A patent/SE8901031L/en not_active Application Discontinuation
- 1989-03-22 ES ES8901049A patent/ES2013408A6/en not_active Expired - Lifetime
- 1989-03-22 DK DK146789A patent/DK146789A/en not_active Application Discontinuation
- 1989-03-23 NL NL8900724A patent/NL8900724A/en not_active Application Discontinuation
- 1989-03-23 GR GR890100185A patent/GR1000876B/en unknown
- 1989-03-23 AU AU31695/89A patent/AU3169589A/en not_active Abandoned
- 1989-03-23 GB GB8906758A patent/GB2219799B/en not_active Expired - Fee Related
- 1989-03-23 IE IE890950A patent/IE890950L/en unknown
- 1989-03-24 FR FR8903952A patent/FR2632321A1/en not_active Withdrawn
- 1989-03-24 LU LU87489A patent/LU87489A1/en unknown
- 1989-03-24 KR KR1019890003761A patent/KR890014743A/en not_active Application Discontinuation
- 1989-03-24 IT IT8919917A patent/IT1234961B/en active
- 1989-03-24 BE BE8900329A patent/BE1004202A5/en not_active IP Right Cessation
- 1989-03-24 JP JP1073723A patent/JPH0279981A/en active Pending
- 1989-03-24 HU HU891515A patent/HUT50501A/en unknown
- 1989-03-27 PT PT90118A patent/PT90118B/en active IP Right Grant
- 1989-03-28 DE DE3910084A patent/DE3910084A1/en not_active Withdrawn
- 1989-03-28 CH CH1114/89A patent/CH681081A5/de not_active IP Right Cessation
-
1992
- 1992-12-04 AU AU29904/92A patent/AU2990492A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FI891308A0 (en) | 1989-03-20 |
IT1234961B (en) | 1992-06-09 |
IE890950L (en) | 1989-09-24 |
GR1000876B (en) | 1993-03-16 |
NZ228427A (en) | 1993-03-26 |
KR890014743A (en) | 1989-10-25 |
ES2013408A6 (en) | 1990-05-01 |
IL89673A0 (en) | 1989-09-28 |
PT90118B (en) | 1994-07-29 |
GB2219799A (en) | 1989-12-20 |
NL8900724A (en) | 1989-10-16 |
PT90118A (en) | 1989-11-10 |
FI891308A (en) | 1989-09-25 |
GR890100185A (en) | 1990-01-19 |
GB2219799B (en) | 1992-10-14 |
DE3910084A1 (en) | 1989-11-16 |
IT8919917A0 (en) | 1989-03-24 |
DK146789A (en) | 1989-09-25 |
BE1004202A5 (en) | 1992-10-13 |
SE8901031L (en) | 1989-09-25 |
FR2632321A1 (en) | 1989-12-08 |
CH681081A5 (en) | 1993-01-15 |
DK146789D0 (en) | 1989-03-22 |
LU87489A1 (en) | 1989-10-26 |
NO891273D0 (en) | 1989-03-22 |
HUT50501A (en) | 1990-02-28 |
GB8906758D0 (en) | 1989-05-10 |
AU2990492A (en) | 1993-03-04 |
JPH0279981A (en) | 1990-03-20 |
AU3169589A (en) | 1989-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231223T2 (en) | HUMAN PF4A RECEPTORS AND THEIR USE | |
ES539678A0 (en) | PROCEDURE FOR PREPARING A CYCLIC POLYPEPTIDE | |
DE50015156D1 (en) | Procalcitonin-targeted antibodies, their production and use | |
ATE164884T1 (en) | NEW SEVEN TRANSMEMBRANE RECEPTOR V28 | |
DE19981132D2 (en) | Functional vitamin D derivatives and method for the determination of 25-hydroxy and 1alpha, 25-dihydroxy vitamin D | |
DE69030579T2 (en) | METHOD FOR PRODUCING FUSION PROTEINS | |
ATE196162T1 (en) | TOXOPLASMA GONDII ANTIGENS, THEIR PRODUCTION AND THEIR USE | |
ATE219040T1 (en) | METHOD FOR PRODUCING SEVOFLURANE | |
SE8901031D0 (en) | NOVEL POLYPEPTIDESHAVING GROWTH FACTOR ACTVIVTY AND ND NUCLEIC ACID SEQUENCES ENCODING THE POLYPEPTIDES | |
DE69207429D1 (en) | METHOD FOR PRODUCING SUBSTITUTED PIPERIDINES | |
ATE48835T1 (en) | QUINOLYLGLYCINAMIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THERAPEUTIC USE AS PSYCHOTROPS. | |
DE3785673T2 (en) | MONOCLONAL ANTIBODY SPECIFIC TO NEUTROPHILES. | |
DE69802811D1 (en) | METHOD FOR PRODUCING POLYBORACYLENE MESOPHASE, POLYBORAZYLENE MESOPHASE, THEIR USE AS BN PRECURSOR | |
ATE37534T1 (en) | ARYLETHANOLHYDROXYLAMINE, PROCESS FOR THEIR PRODUCTION AND USE TO ENHANCE PERFORMANCE. | |
ES8801378A1 (en) | Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides. | |
DK0617027T3 (en) | N-Benzylpiperazine Compounds, Methods of Preparation and Compositions Containing the Compounds | |
DE3671603D1 (en) | METHOD FOR THE BREEDING OF BABESIA CANIS, USE FOR THE PRODUCTION OF ANTIGENS AND VACCINALS AND ANTIGENS AND VACCINATES AGAINST PIROPLASMOSIS. | |
DE59005353D1 (en) | 1-bromo-3-chloro-1,2-diaryl-2-propanols, process for the stereoselective preparation of the erythro-1-bromo-3-chloro-1,2-diaryl-2-propanols and their conversion to azolylmethyloxiranes. | |
DE3677270D1 (en) | CHINOLIN-8-CARBONIC ACID AZOLIDE, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS HERBICIDES. | |
DE69004320D1 (en) | Hydroxyphenethylamine derivative and its salts, process for its manufacture, medical use and use as a specific pharmacological tool. | |
ATA230385A (en) | DEVICE FOR PRODUCING LOW-ALKALINE CEMENT CLINKER | |
DE69405507T2 (en) | Intermediates for the production of vitamin A and carotenoids and process for their production | |
Young | Cements Research Progress, 1981 | |
RU94016916A (en) | METHOD FOR PRODUCING 5- [3- (4) -R-1-ADAMANTYL] PYRIMIDINES | |
DE10075006I1 (en) | Use of (s) (+) - 2-aethoxy-4- N- 1- (2piperidino-phenyl) -3-methyl-1-butyl aminocarbonylmethyl-benzoic acid for the preparation of a long-term antidiabetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 8901031-8 Effective date: 19941001 |